Newsfiscal.ai
Eikon Therapeutics Presents Clinical Data for PARP1 and WRN Helicase Programs at ESMO 2026
· Published
Article summary
Eikon Therapeutics announced the presentation of initial and updated clinical data for its EIK1003, EIK1004, and EIK1005 programs at the 2026 European Society for Medical Oncology (ESMO) Congress.
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…